Plant Advanced Technologies

Back to previous page


Name: Plant Advanced Technologies
Market: Euronext Growth Paris
Subsector: Biotechnology
Isin code: FR0010785790
Trading code: ALPAT
Symbol: ALPAT


IPO Date: 08/04/2015
Issue type: Initial Public offering
Price range: EUR 27.00 - 33.00

Company Profile

Loading... Please wait.


Date Title
08 Apr 2015 Plant Advanced Technologies (PAT) lists on Alternext Paris expand

Raises €7 million, market capitalisation totals €26 million

Paris – 8 April 2015– EnterNext, the Euronext subsidiary dedicated to promoting and growing the market for SMEs[1],today congratulated Plant Advanced Technologies (PAT), a company specialised in identifying and producing rare plant molecules, on its successful listing on Alternext in Paris.

Founded in 2005, Plant Advanced Technologies (PAT) identifies, optimises and produces rare plant-based biomolecules for pharmaceuticals, cosmetics and green chemistry. The company’s product portfolio includes 26 active compounds, one already recognised internationally, and some 20 that will be on the market in the next five years for the treatment of aging, inflammation, cancer, Alzheimer’s disease and more. PAT's innovative technologies (PAT plant milking® and PAT Friday®) make for very strong growth potential in fast-growing markets.

Plant Advanced Techonologies (ticker symbol: ALPAT) was listed through the admission to trading of 867,521  ordinary shares, including 230,000 new shares issued under a Global Offering[2] after full exercise of the extension clause and before a potential over-allotment option.

The admission price and issue price of Plant Advanced Technologies was set at €30 per share. Market capitalisation on the day of listing was €26 million, and the operation raised a total of €6.9 million

Jean-Paul Fèvre, Plant Advanced Technologies’ co-founder and Chairman & CEO, said: “We are delighted that our listing has proved so popular, especially with such a large number of individual investors. Listing on Alternext is a milestone for PAT and will enable us to step up our growth. I would like to extend our sincere thanks to all of the individual and institutional investors who took part in this IPO for their trust and support.”

Eric Forest, Chairman and CEO of EnterNext, said “We are very pleased with successful listing of plant biotech specialist Plant Advanced Technologies. This transaction confirms the stockmarket’s appeal for innovative companies, allowing them to raise the capital they need to step up the pace of development. Plant Advanced Technologies is now part of a community of over 320 listed tech companies whose investor profiles are being boosted by tools developed by Euronext.”

[1]Small and medium-size companies
TheGlobal Offering was made up of a Public Offering that included an Open Price Public Offering and a Global Placement with institutional investors in France and other countries


08 Apr 2015 Plant Advanced Technologies expand

EnterNext welcomes Plant Advanced Technologies on Alternext in Paris

Jean-Paul Fèvre, Founder and CEO of Plant Advanced Technologies (symbol: ALPAT), rings the opening bell.

Plant Advanced Technologies specializes in producing plant molecules and extracts for the pharmaceutical and cosmetic sectors. The company offers research contracts to industrial firms for updating technologies on new plants and supply contracts for molecules obtained from these plants.